Many viruses have developed integral membrane proteins to transport ions and other molecules across the membrane barrier to aid various steps of viral entry and maturation^[@R9],[@R10]^. These membrane structures, known as viroporins, usually adopt minimalist architectures that are significantly different from those of bacterial or eukaryotic ion channels. Therefore, understanding the structural basis of how viroporins function broadens our knowledge of channels and transporters while generating new opportunities for therapeutic intervention.

The viroporin formed by the HCV p7 protein has been sought after as potential anti-HCV drug target^[@R5],[@R11]^. p7 is a 63-residue membrane protein that oligomerizes to form ion channels with cation selectivity, for Ca^2+^ over K^+^ and Na^+[@R2],[@R3],[@R12],[@R13]^, and more recent studies also reported p7-mediated H^+^ intracellular conductance^[@R14]^. The p7 channel is required for viral replication1^[@R5]^; it has been shown to facilitate efficient assembly and release of infectious virions^[@R16],[@R17]^, though the precise mechanism of these functions remains unclear. The channel activity can be inhibited by adamantane and long alkylchain iminosugar derivatives and hexamethylene amiloride *in vitro*, with varying reported efficacies^[@R2],[@R3],[@R12],[@R13]^. In addition to ion conduction, p7 has been shown to specifically interact with the non-structural HCV protein NS2, suggesting that its channel activity could be regulated^[@R18],[@R19]^.

There is not yet a detailed structure of the p7 channel, though a number of pioneering NMR studies showed that the p7 monomer has three helical segments: two in the N-terminal half of the sequence and one near the C-terminus^[@R12],[@R20]^. A single-particle electron microscopy (EM) study obtained a 16 Å resolution electron density map of the p7 oligomer using the random conical tilting approach^[@R4]^. The map shows that the p7 channel is a 42 kDa hexamer and adopts a flower-like shape that does not resemble any of the known ion channel structures in the database.

How does the small p7 polypeptide assemble into what appears to be a complex channel structure? Has the viroporin adopted novel structural elements for cation selectivity and channel gating? Amantadine or rimantadine blocks the influenza M2 channel by binding to the small pore formed by four transmembrane helices^[@R21]-[@R23]^, but the pore of the p7 hexamer is expected to be much bigger and it is thus unclear how would these small molecules fit. We sought to address these important questions by determining detailed structures of the p7 hexamer and its drug-binding site.

We systematically tested p7 amino acid sequences from various HCV genotypes and found that the sequence from genotype 5a (EUH1480 strain) generated samples that were sufficiently soluble for structure determination ([Supplementary Fig. 1](#SD2){ref-type="supplementary-material"}). This p7 construct, designated here as p7(5a), could be efficiently reconstituted in dodecylphosphocholine (DPC) micelles at near physiological pH and generated high quality NMR spectra ([Supplementary Fig. 2](#SD2){ref-type="supplementary-material"}). Negative-stain EM of the DPC-reconstituted p7(5a) in NMR buffer showed hexameric, flower-shaped particles that are similar to those in the electron micrographs of the p7 (JFH-1 strain, genotype 2a) hexamer in dihexanoyl-phosphatidyl-choline (DHPC) micelles used earlier for single-particle reconstruction^[@R4]^ ([Supplementary Fig. 3](#SD2){ref-type="supplementary-material"}). Moreover, isothermal titration calorimetry and NMR chemical shift perturbation analyses of p7(5a)-rimantadine interaction showed that the drug binds specifically to the reconstituted protein with a binding constant (K~d~) from 50-100 μM at 3 mM detergent concentration ([Supplementary Fig. 4&5](#SD2){ref-type="supplementary-material"}). The above results together indicate that the p7(5a) polypeptides reconstituted in DPC micelles form structurally relevant hexamers.

Structure determination of the p7(5a) hexamer by NMR employed approach taken earlier for oligomeric membrane proteins^[@R24]-[@R26]^, which involves 1) determination of local structures of the monomers and 2) assembly of the oligomer with intermonomer distance restraints and orientation constraints. The NMR-derived restraints define an ensemble of structures with backbone r.m.s. deviation of 0.74 Å ([Fig. 1a](#F1){ref-type="fig"}). Each monomer consists of an N-terminal helix (H1) from residues 5-16, a middle helical segment (H2), with a kink at Gly34, from residues 20-41, and a C-terminal helix (H3) from residues 48-58. These secondary structures are consistent with earlier NMR studies of p7 monomers in DHPC detergent and organic solvent^[@R12],[@R20]^. There are no intramonomer contacts ([Fig. 1a](#F1){ref-type="fig"}). The monomers are intertwined to form a tightly packed channel, where H1 and H2 form the channel interior and H3 is lipid-facing and packs against H2 of the *i*+2 and H1 of the *i*+3 monomer ([Fig. 1a&b](#F1){ref-type="fig"}). The intermonomer association between H3 and H2 appears to be stabilized by interaction involving conserved residues such as Trp30, Tyr42, and Leu52, and the contacts between H3 and H1 are mostly between the alanine rich region of H1 (residues 10-15) and Ala61 and Ala63 of H3 ([Fig. 1c](#F1){ref-type="fig"}). The overall structure of the p7(5a) hexamer has a flower-like shape that agrees with the EM map (EM database ID:1661), fitting to the map with a correlation coefficient of 0.94 ([Fig. 1d](#F1){ref-type="fig"}).

The channel cavity has a funnel profile that resembles a champagne flute and is largely hydrophilic ([Fig. 2a](#F2){ref-type="fig"}). The H2 helices form the wide cylindrical region (internal diameter, I.D. \~12 Å) by packing with each other at large angles (angle between adjacent helices \~ -47°), and the H1 helices assemble at smaller packing angles (\~ -34°) to form the narrow conical region of the funnel (smallest I.D. at 6.8 Å). Residues 17-19 constitute the flexible joint between H1 and H2; their NMR resonances are significantly broader than other regions of the protein, suggesting the presence of conformational exchange.

The channel architecture described above represents a novel topology and exemplifies how HCV has optimized the short p7 polypeptide to achieve a rather complex channel structure. What are then the elements for cation conduction and gating? An in-depth examination of the channel interior found two strongly conserved polar residues with salient structural features ([Fig. 2b](#F2){ref-type="fig"}). One is Asn9, which forms a ring of carboxamide that constricts the conical region of the channel ([Fig. 2c](#F2){ref-type="fig"}). Residue 9 is asparagine in all strains except being substituted with histidine in genotype 2 viruses. Both asparagines and histidines have affinity for monovalent and divalent cations. We hypothesize that the Asn9 ring serves as a broad selectivity filter that dehydrates cations, allowing them to pass the hydrophobic ring formed by Ile6. The Ile6 ring defines the narrowest point of the channel and likely serves as a hydrophobic gate. Another feature is the Arg35 ring that defines the wider, C-terminal end of the channel ([Fig. 2b](#F2){ref-type="fig"}). Placement of a positively charged ring on the other end of the pore was incomprehensible to us initially because it can repel cations. But the recent structure of an Orai Ca^2+^ channel also revealed a stretch of basic residues in the ion conducting pore^[@R27]^. We hypothesize that one of the Arg35 roles is to bind and obstruct anions at the pore entrance while allowing cations to diffuse into the pore. In this model, cation conduction is unidirectional from the C- to N-terminal end of the channel.

To test the above hypotheses, we established an assay that uses the two-electrode voltage-clamp technique to record p7-mediated current in *Xenopus* oocytes (METHODS). Due to the poor stability of oocytes that overexpress p7(5a), p7 (JFH-1 strain, genotype 2a) was used instead for these experiments. As expected of the proposed role of residue 9 in selectively dehydrating cations, replacing His9 of p7(2a) with alanine caused \~70% reduction in channel conductance at +80 mV ([Fig. 2d](#F2){ref-type="fig"}). The proposed role of Arg35 infers that placing negatively charged residues at the channel entrance would bind cations and hinder their diffusion into the pore, and indeed the R35D mutation also reduced conductance by \~70% ([Fig. 2d](#F2){ref-type="fig"}).

We next investigated the mechanism of amantadine binding to the p7 channel using proteins that are ^15^N-labeled and deuterated so that Nuclear Overhauser Enhancement (NOE) between the protein backbone amide protons and drug protons could be measured unambiguously. At 10 mM amantadine (not corrected for drug partitioning to detergent micelles), the ^15^N-edited NOESY spectrum showed NOE crosspeaks between the adamantane protons and the amide protons of Val26, Leu55, Leu56, and Arg57 ([Fig. 3a](#F3){ref-type="fig"}). We then identified contacts between the drug and protein sidechains using protein that is (^1^H/^13^C)-labeled at the methyl positions of alanines, valines and leucines but is otherwise deuterated. In this case, the ^13^C-edited NOESY showed several methyl-drug NOEs ([Fig. 3b](#F3){ref-type="fig"}).

These NOEs were used to dock amantadine into the structure determined in the absence of drug. In doing so, we emphasize that the relevance of the p7-amantadine complex is confined to only the drug binding region because we do not know how and to what degree does drug binding alter the global conformation of the channel. The relatively poor stability of the protein-drug complex at the current stage of our study precludes full-scale structure determination. Nonetheless the available NMR data show that the drug adamantane binds to six equivalent hydrophobic pockets between the pore-forming and peripheral helices ([Fig. 3c](#F3){ref-type="fig"}). The pocket consists of Leu52, Val53, and Leu56 from H3, and Phe20, Val25, and Val26 from H2. The amantadine amino group on average points to the channel lumen. The same NOESY spectrum as above recorded using a sample with 5 mM rimantadine indicates that rimantadine binds to the same pocket with the methyl and amino groups pointing to the lumen ([Supplementary Fig. 6](#SD2){ref-type="supplementary-material"}).

The binding site is overall consistent with mutational study showing that mutations in residues 50-55 significantly reduced drug sensitivity of the channel^[@R28]^. It is also consistent with a L20F mutation in genotype 1b virus originally identified in clinical trials that confers amantadine resistance^[@R8],[@R29]^. In the p7(5a) structure, residue 20 is an integral part of the drug pocket and is in direct contact with the drug adamantane. Therefore, replacing Leu20 in p7(1b) with phenylalanine is expected to reduce hydrophobic interaction with the drug. Elucidation of previous functional data in the context of the structure suggests that the binding site shown in [Fig. 3c](#F3){ref-type="fig"} is relevant to drug inhibition and that interactions between the drug adamantane and protein hydrophobic residues are critical for inhibition. Variations in the hydrophobicity of the binding pocket among the p7 variants ([Supplementary Fig. 7](#SD2){ref-type="supplementary-material"}) thus explain the large differences in drug efficacies observed between different HCV genotypes.

We have learnt from KcsA and other channels that a gated ion channel generally adopts two essential features: pore elements that provide ion selectivity and gating mechanism that can transiently open the channel to allow ion permeation. By virtue of being a funnel, the p7 structure suggests that the tip of the funnel represented by the Ile6 and Asn9 rings is the key region for channel gating ([Fig. 4](#F4){ref-type="fig"}). The role of the Asn9 ring is to provide ion selectivity by recruiting and dehydrating cations near the funnel exit, whereas the Ile6 ring is a hydrophobic constriction that would prevent water from freely passing through. Channel activation may involve reorientation of the H1 helices that widens the funnel tip, analogous to the dynamic C-terminal helix of KcsA^[@R30]^, and such structural rearrangement can be afforded by the flexible hinge between H1 and H2, the intervening loop between H2 and H3, and the C-terminal tail that "latches" onto H1. We thus propose that binding of adamantane derivatives inhibit channel activity by restricting the structural rearrangement. Our NMR titration data ([Supplementary Fig. 5c](#SD2){ref-type="supplementary-material"}) is consistent with this proposal, which showed that in the absence of rimantadine, the Ile6 methyl resonance is split into an intense and weak peak, possibly corresponding to the open and closed state, respectively, and that increasing the drug concentration shifted the equilibrium that made the weak peak stronger. Although rigorous testing of the model is needed, the preliminary observation suggests the existence of multiple states of the p7 channel.

METHODS {#S2}
=======

Sample Preparation {#S3}
------------------

The amino acid sequence of p7 from genotype 5a was slightly modified to allow for efficient reconstitution and protein sample stability. In this sequence, Thr1 is replaced with Gly, Ala12 is replaced with Ser, and the three cysteines at positions 2, 27, and 44 are replaced with Ala, Thr, and Ser, respectively ([Supplementary Fig. 1](#SD2){ref-type="supplementary-material"}). The p7(5a) construct was cloned, expressed and purified as previously described^[@R1],[@R2]^. Briefly, the protein was expressed as a fusion to His9--trpLE that formed inclusion bodies. The peptide was released from the fusion protein by CNBr digestion and subsequently separated on a Proto-18C column by reverse-phase chromatography (more details given in [Supplementary Methods](#SD2){ref-type="supplementary-material"}). The lyophilized peptide was then dissolved in 6 M guanidine and DPC and refolded by dialysis against the NMR buffer. A typical NMR sample contains 0.8 mM protein (monomer concentration), 200 mM DPC, and 25 mM MES (pH 6.5).

Assignment of NMR resonances {#S4}
----------------------------

All NMR experiments were conducted at 30 °C on Bruker spectrometers equipped with cryogenic probes. Sequence specific assignment of backbone chemical shifts was accomplished using three pairs of triple resonance experiments, recorded using a ^15^N/^13^C/^2^H labeled sample. The triple resonance experiments were relaxation optimized (TROSY)^[@R3]^, including HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, HN(CA)CO, and HNCO^[@R4]^. Protein sidechain aliphatic and aromatic resonances were assigned using a combination of NOESYs including ^15^N-edited NOESY-TROSY (60 ms NOE mixing time, τ~NOE~) and ^13^C-edited NOESY-HSQCs (τ~NOE~=100 ms). Specific stereo assignment of the methyl groups of valines and leucines were obtained from a constant-time ^1^H-^13^C HSQC spectrum recorded using a 15% ^13^C-labeled sample^[@R5]^.

Assignment of local NOEs for determining the secondary structures {#S5}
-----------------------------------------------------------------

The same ^15^N-edited NOESY-TROSY and ^13^C-edited NOESY-HSQC above with short τ~NOE~ were used to assign local NOEs. Combining the NOE restraints with chemical shifts, we could very precisely define the helical and loop regions of the individual monomers.

Measurement of residual dipolar coupling (RDC) constants {#S6}
--------------------------------------------------------

The backbone ^1^H-^15^N RDCs were measured using a modified approach^[@R6]^ of the strain-induced alignment in a gel method^[@R7],[@R8]^. In this experiment the p7(5a) channel in DPC micelles was soaked into a cylindrically shaped polyacrylamide gel (4.5%), initially of 6 mm diameter, which was subsequently radially compressed to fit within the 4.2 mm inner diameter of an open-ended NMR tube. The ^1^H-^15^N RDCs were obtained from ^1^*J*~NH~/2 and (^1^*J*~NH~+^1^*D*~NH~)/2, which were measured by interleaving a regular gradient-enhanced HSQC and a gradient-selected TROSY^[@R9]^. The largest ^1^H-^15^N RDC measured is 33.5 Hz.

Assignment of intermonomer NOEs {#S7}
-------------------------------

Intermonomer NOEs between protein backbone amide and sidechain methyl protons was assigned using a sample that was reconstituted with a 1:1 mixture of ^15^N-, ^2^H-labeled p7(5a) peptide and ^13^C-labeled peptide. Recording a ^15^N-edited NOESY-TROSY (τ~NOE~=300 ms) on a 900 MHz spectrometer with this sample allowed exclusive detection of NOE crosspeaks between the ^15^N-attached protons of one monomer and the ^13^C-attached protons of other monomers. The intermonomer NOEs between the neighboring H1 helices and neighboring H2 helices effectively defined the central cavity formed by these helices. The initial structural solution of the pore assembly then allowed us to assign complementary and self-consistent intermonomer NOEs between the aliphatic and aromatic protons in a pair of ^15^N-edited NOESY-TROSY and ^13^C-edited NOESY-HSQC recorded using a ^15^N-, ^13^C-labeled sample. These spectra were recorded with τ~NOE~ of 120 ms and 150 ms, respectively.

The packing of H1 and H2 helices between the adjacent monomers and RDC-derived orientation constraints together positioned the H3 helix of monomer *i* to be in contact with H2 of the *i*+2 and H1 of the *i*+3 monomers, and this conformation was confirmed by the unambiguous amide-methyl NOEs between H3 and H1/H2. The conformation as defined by the intermonomer NOEs was subject to numerous rounds of self-consistency test with the NOE crosspeaks in the ^13^C-edited NOESY-HSQC spectrum to ensure that all NOEs are consistent with the structure. The overall distribution of intermonomer NOEs is illustrated in [Supplementary Fig. 7](#SD2){ref-type="supplementary-material"}.

Assignment of NOEs between protein and drug {#S8}
-------------------------------------------

We prepared a sample containing ^15^N-, ^2^H-labeled p7(5a), 10 mM amantadine (or 5 mM rimantadine), and perdeuterated DPC. The sample was used to record a ^15^N-edited NOESY-TROSY (τ~NOE~=300 ms) on a 900 MHz spectrometer. This experiment allowed exclusive detection of NOEs between the exchangeable amide protons and the drug protons. For assigning NOEs between the protein sidechain methyl protons and the drug protons, we prepared the ALV-labeled protein that is ^1^H-, ^13^C-labeled at the methyl positions of alanines, valines and leucines but is otherwise deuterated. The NOEs were measured using a ^13^C-edited NOESY with diagonal suppression, i.e., interleaving two experiments: one with NOE mixing (300 ms) of the H~z~ magnetization (NOE crosspeaks) and the other with mixing of the H~z~C~z~ magnetization (no NOE crosspeaks)^[@R10]^. Subtracting the two spectra mostly cancelled the strong methyl diagonal peaks (\~0.8 ppm) and thereby unveiled the weak methyl-drug NOEs at \~1.7 ppm.

Structure calculation of the p7(5a) hexamer {#S9}
-------------------------------------------

Structures were calculated using the program XPLOR-NIH^[@R11]^. The monomer structures (mainly the secondary structures) were first calculated using intramonomer NOE-derived distance restraints, backbone dihedral restraints derived from chemical shifts using the TALOS program^[@R12]^, and RDC restraints. A total of 10 monomer structures were calculated using a standard simulated annealing (SA) protocol. Six copies of the lowest-energy monomer structure were used to construct an initial model of the hexamer using intermonomer NOE restraints collected from the mixed-labeled sample for the H1 and H2 helical segments. For each intermonomer restraint between two adjacent monomers, six identical distance restraints were assigned respectively to all pairs of neighboring monomers to satisfy the condition of C6 rotational symmetry (as indicated by the EM data). The assembled hexamer was then subject to refinement against RDCs to accurately orient the three helical segments. Finally, using the SA protocol, the hexamer was refined against the complete set of NOE restraints (including intramonomer and intermonomer distance restraints), dihedral restraints, and RDC restraints. A total of 60 hexamer structures were calculated and 15 low energy structures were selected as the structural ensemble. Ramachandran plot statistics for the structure ensemble, calculated using PROCHECK^[@R13]^, are as follows: most favored (96.6%), additionally allowed (2.8%), generously allowed (0.6%) and disallowed (0.0%).

Whole-cell channel recording assay for p7 {#S10}
-----------------------------------------

The cRNA of p7(2a) variants were synthesized and injected into *Xenopus laevis* oocytes at \~15 ng per oocyte. After about 16-30 hours of expression, healthy oocytes were collected and subject to channel recording using the two-electrode voltage-clamp technique^[@R14]^. The oocytes were first bathed in standard ORi solution (90 mM NaCl, 2 mM KCl, 2 mM CaCl~2~, and 5 mM MOPS, pH 7.4) before impaled with two microelectrodes. For recording p7-mediated current, we used a voltage-clamp protocol consisting of rectangular voltage steps from −100 to +80 mV in 10 mV increments, applied from a holding voltage of −60 mV. Expression levels of the p7 variants in oocytes were examined by confocal microscopy using HA-tagged p7. More experimental details are described in [Supplementary Methods](#SD2){ref-type="supplementary-material"}.
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======================
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The structure will be deposited in the Protein Data Bank under the accession number 2M6X.

###### NMR structure of the p7(5a) hexamer and its comparison to the EM map

**a**, Ensemble of 15 low-energy structures calculated using NMR restraints summarized in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}. **b**, Two-dimensional drawing illustrating the intermonomer interactions among the H1, H2, and H3 helical segments that are responsible for the hexameric assembly. **c**, Three-dimensional cartoon representation describing the global arrangement of helical segments and amino acids that appear to play a role in the packing of H3 against H1 and H2. **d**, Fitting the lowest energy structure from the ensemble to the 16 Å EM map (EM database ID:1661)^[@R4]^. The fitting correlation is 0.94 as calculated with the program Chimera.
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![The pore properties of the p7(5a) channel\
**a**, The pore surface calculated using the program HOLE, showing the shape and constrictions of the pore. **b**, Sectional view of the channel showing the pore-lining residues with residues in red being strongly conserved. The numbers next to the helical segments represent the monomers to which the helices belong. **c**, A close view of the rings formed by Asn9 and Ile6 that constrict the N-terminal end of the channel. **d**, The current-voltage relationships of wildtype p7(2a) and the H9A and R35D mutants. Each data point is the mean ± SEM (standard error of mean) calculated over measurements from six different oocytes (n=6).](nihms471458f2){#F2}

![NMR characterization of the amantadine binding site\
**a**, Representative strips from the 3D ^15^N-edited NOESY-TROSY spectrum (300 ms NOE mixing time) recorded using a sample containing ^15^N-, ^2^H-labeled p7(5a) and 10 mM amantadine, showing amantadine NOEs to the backbone amide protons of Val26, Leu55, Leu56, and Arg57. **b**, Representative strips from the 3D diagonal-suppressed ^13^C-edited NOESY-HSQC spectrum recorded using a sample that is ^1^H-, ^13^C-labeled at the methyl positions of alanines, valines and leucines but is otherwise deuterated, showing drug NOEs to the sidechain methyl protons of Val26, Leu52, and Val53. The spectra in **a** and **b** were recorded at ^1^H frequency of 900 MHz. **c**, Amantadine docked into the p7(5a) hexamer using restraints from NOEs in **a** and **b** (left) and a close view of amantadine in the binding pocket (right).](nihms471458f3){#F3}

![A model for amantadine or rimantadine inhibition of the p7 channel\
The two-dimensional cartoon drawing mimics the sectional view of the p7 channel in [Fig. 2b](#F2){ref-type="fig"}. The channel undergoes conformational switching between the closed and the open states but favors the open state in the presence of cations (blue circles). Binding of amantadine or rimantadine (green circle) favors the closed state by restricting movements of the three helical segments that may be required for channel opening.](nihms471458f4){#F4}
